OSE Immunotherapeutics SA

EPA:OSE.PA

6.05 (EUR) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42012 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 16.74575.74618.67215.01825.6231.19333.57927.26429.36822.9225.8421.8179.57315.7589.64617.63714.8859.0759.33218.3571.1112.7410.280.185
Short Term Investments 0000000000024.712.8612.8892.8822.8862.8816.25.80100000
Cash and Short Term Investments 16.74575.74618.67215.01825.6231.19333.57927.26429.36822.9225.84226.52712.43418.64712.52820.52317.76615.27515.13318.3571.1112.7410.280.185
Net Receivables 4.1387.5540.9820.234000.77211.3771.0743.3180.7471.1782.2533.8060012.32310.69800.10000
Inventory 02.4660000000000000000000000
Other Current Assets 49.0492.4852.74512.4633.4524.0052.9643.45511.8869.7187.222.8951.471.5532.9030.430.5190.1271.7430.7280.8160.0870.0280.004
Total Current Assets 69.93285.78530.47827.71537.245.92844.20642.09639.83233.28333.06239.11223.02430.88623.98626.47836.53829.9116.87619.0851.9272.8280.3080.254
Non-Current Assets:
Property, Plant & Equipment, Net 3.4253.6474.074.3014.9795.4695.4392.8423.7954.0882.7012.8210.9040.8170.4290.1190.110.0930.0650.0240.025000
Goodwill 000000000000000000000000
Intangible Assets 045.21146.40147.60448.78449.95751.12252.17252.652.652.652.652.652.652.652.652.652.6000000
Goodwill and Intangible Assets 44.0145.21146.40147.60448.78449.95751.12252.17252.652.652.652.652.652.652.652.652.652.6000000
Long Term Investments 6.46.0840.7560.5870.5240.7310.5810.9410.5810.6070.2440.102-51.968-52.048-52.432-52.636-52.647000000.0280
Tax Assets 0.1910.1940.1950.1840.1830.1810.1730.1630.1650.1670.2830.2760.2720.2650.2610.1550.1570000000
Other Non-Current Assets 0.001-00000000000-0.904-0.817-0.429-0.119-0.11-52.6-0.065-0.024-0.0250.028-0.0280
Total Non-Current Assets 54.02755.13651.42252.67654.4756.33857.31556.11857.14157.46255.82855.7990.9040.8170.4290.1190.110.0930.0650.0240.0250.0280.0280.028
Total Assets 123.959140.92181.980.39191.67102.266101.52198.21496.97390.74588.8994.91176.90384.62577.35379.44789.54782.65216.99519.2791.982.8560.3360.282
Liabilities & Equity:
Current Liabilities:
Account Payables 7.7248.3446.4919.4214.56313.6253.11313.0827.5447.814.2843.6194.8265.3746.1961.832.521.8111.0120.2311.3060.230.0260.006
Short Term Debt 7.7943.9217.2616.2913.9763.692.3670.7460.6441.1070.8610.9450.6280.650.590.5370.5870.8160.7760.7480.284000
Tax Payables 000.020.0180.0210.0280.0140.0040.0020.0030.020.0921.3170.9610.1620.022.1030.140.0050.0040.0020.0010.0030.008
Deferred Revenue 02.8940.3470.1480.8121.6981.0463.730.0020.0034.81112.088-0.627-0.648-0.59-0.538-0.587-0.816-0.776-0.748-0.284000
Other Current Liabilities 4.7032.2274.682.6646.8962.14310.2222.7875.9385.4194.3543.9131.7313.1717.5493.0662.7894.930.5111.0080.29700.0240.07
Total Current Liabilities 20.22117.38618.79918.54216.26821.18416.76220.34914.12814.33914.3320.6579.07511.98314.49713.26918.6637.6972.3051.9911.8890.2310.0530.084
Non-Current Liabilities:
Long Term Debt 38.33839.96438.5437.46740.81732.08234.76723.17918.8718.72210.6246.0443.8324.1034.2963.3351.1971.3710.2040.60.8941.1561.1470.831
Deferred Revenue Non-Current 0.12.8123.0323.1573.5863.9843.9651.4262.3182.571.4131.5511.8220.6031.43-0.654-3.806-4.208000000
Deferred Tax Liabilities Non-Current 1.0741.6581.3111.431.5141.6311.7481.8022.080.8025.0665.1892.013.52.8663.9995.0035.579000000
Other Non-Current Liabilities 0.415-2.3470.4290.4230.5242.2020.7090.5780.5310.460.3770.292.2420.2710.2480.1980.1590.062000000
Total Non-Current Liabilities 39.92742.08740.2839.3242.85534.28437.22425.55921.48119.98416.06711.5233.8324.1034.2963.3451.1971.3710.2040.60.8941.1561.1470.831
Total Liabilities 60.14859.47359.07957.86259.12355.46853.98645.90835.60934.32330.39732.1815.14919.85721.90720.80125.02214.7092.5192.6012.7831.3871.20.915
Equity:
Preferred Stock 003.430000000000000002.642.8791.2731.2641.1420
Common Stock 4.3884.3664.333.8063.7053.7053.7053.6573.5973.0893.0012.9932.9632.9322.8982.8752.8582.852.012.0021.6051.5980.5270.527
Retained Earnings -17.8711.046-57.281-46.563-35.889-21.862-21.11-16.76719.23831.89434.11338.3225.498.877-10.503-6.3420.66624.506-5.584-2.942-2.835-0.655-0.25-1.436
Accumulated Other Comprehensive Income/Loss 0-0.393-0.309-0.228-0.22-0.203-0.15-0.0838.96635.008-0.1-0.07431.76131.44441.49940.58519.42119.185-2.64-2.879-1.273-1.264-1.1420
Other Total Stockholders Equity 77.29476.42941.80330.81146.93345.27560.8370.77838.529-13.5689.541-16.31853.30152.95963.05121.52621.5821.40215.4120.4971.7-0.7380.0010.276
Total Shareholders Equity 63.81181.44822.82122.52932.54746.79847.53552.30661.36456.42358.49362.73161.75464.76855.44658.64664.52567.94314.47616.678-0.8031.469-0.864-0.633
Total Equity 63.81181.44822.82122.52932.54746.79847.53552.30661.36456.42358.49362.73161.75464.76855.44658.64664.52567.94314.47616.678-0.8031.469-0.864-0.633
Total Liabilities & Shareholders Equity 123.959140.92181.980.39191.67102.266101.52198.21496.97390.74588.8994.91176.90384.62577.35379.44789.54782.65216.99519.2791.982.8560.3360.282